Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jan 2023 for Harvard Bioscience INC, €7,586. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael A. Rossi: trading record in brief
Michael A. Rossi (finance chief) discloses dealings in Harvard Bioscience Inc to SEC (Form 4). The record holds 7 filings, for trades running from 11 June 2021 to 29 December 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 3 January 2023 with a share grant (€7,586) in Harvard Bioscience Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael A. Rossi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,162 shares@ US$2.5523.2% of flowCommon StockSEC:0000921895-23-000013:0
7,008 shares@ US$3.6376.8% of flowCommon StockSEC:0000921895-22-002258:0
6,325 shares@ US$3.950.079% mcap15.3% of flowCommon StockSEC:0000921895-22-001987:0
31,021 shares0Common StockSEC:0001193805-22-000420:0
3,163 shares@ US$7.2723.0% of flowCommon StockSEC:0000921895-22-000035:0
6,966 shares@ US$7.5750.4% of flowCommon StockSEC:0000921895-21-001884:0
21,546 shares0Common StockSEC:0000921895-21-001649:0
7 of 7 declarations
